Alison Bybee
Impact in
- Molecular Biology top 5%
- Inflammasome and immune disorders
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 21
- Inflammasome and immune disorders 8
- Oncology 7
- Cancer-related Molecular Pathways 6
- Co-authors
- Philip Nigel Hawkins (24 shared papers)Helen Jane Lachmann (19 shared papers)Mark B. Pepys (11 shared papers)David Richmond Booth (4 shared papers)Julian David Gillmore (8 shared papers)Janet A. Gilbertson (11 shared papers)Jeff Herbert (2 shared papers)Daniel A. Mitchell (2 shared papers)
- Journals
- Carcinogenesis (2 papers)Amyloid (2 papers)British Journal of Haematology (2 papers)Blood (1 paper)The Lancet (1 paper)
- Partner nations
- United KingdomUnited StatesIreland
In The Last Decade
Alison Bybee
44 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 1.5k
- Rheumatology 293
- Immunology 269
- Hematology 124
- Oncology 140
Countries citing papers authored by Alison Bybee
This map shows the geographic impact of Alison Bybee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Bybee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Bybee more than expected).
Fields of papers citing papers by Alison Bybee
This network shows the impact of papers produced by Alison Bybee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Bybee. The network helps show where Alison Bybee may publish in the future.
Co-authors
The 25 scholars most cited alongside Alison Bybee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 524 | |
| 2 | 1999 | 422 | |
| 3 | 2006 | 317 | |
| 4 | 2003 | 165 | |
| 5 | 2006 | 149 | |
| 6 | 2012 | 85 | |
| 7 | 2006 | 78 | |
| 8 | 2006 | 62 | |
| 9 | 2004 | 54 | |
| 10 | 2004 | 52 | |
| 11 | Proto-oncogenic properties of the DP family of proteins. | 1995 | 48 |
| 12 | 2006 | 46 | |
| 13 | 2004 | 44 | |
| 14 | Molecular and functional characterisation of E2F-5, a new member of the E2F family. | 1995 | 40 |
| 15 | 1999 | 37 | |
| 16 | 2000 | 37 | |
| 17 | 1999 | 35 | |
| 18 | The phosphorylation state of the retinoblastoma (RB) protein in G0/G1 is dependent on growth status. | 1991 | 33 |
| 19 | The retinoblastoma protein is partially phosphorylated during early G1 in cycling cells but not in G1 cells arrested with alpha-interferon. | 1992 | 28 |
| 20 | 2005 | 27 |
About Alison Bybee
Alison Bybee is a scholar working on Molecular Biology, Oncology, Hematology, Hepatology and Immunology, having authored 46 papers that have together received 2.4k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (21 papers), Inflammasome and immune disorders (8 papers), Cancer-related Molecular Pathways (6 papers), Liver physiology and pathology (3 papers), Carcinogens and Genotoxicity Assessment (2 papers), Multiple Myeloma Research and Treatments (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Rheumatology (293 citations), Immunology (269 citations), Hematology (124 citations) and Oncology (140 citations). Alison Bybee has collaborated with scholars based in United Kingdom, United States and Ireland. Frequent co-authors include Philip Nigel Hawkins, Helen Jane Lachmann, Mark B. Pepys, David Richmond Booth, Julian David Gillmore, Janet A. Gilbertson, Jeff Herbert, Daniel A. Mitchell, Glenys A. Tennent and J. Ruth Gallimore. Their work appears in journals such as Carcinogenesis, Amyloid, British Journal of Haematology, Blood and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.